With the support of Giant Food, the Next Gen Award was created in 2013 to recognize young Investigators who are committed to pursuing a long-term career in Pediatric Oncology research. Funding is made possible through Giant Food’s Triple Winner Program. CCF is grateful to Giant Food for this support.
An independent Review Board receives and reviews proposals from the area and selects one submission to receive the award.
2017 Next Gen Award Winner: Dr. Haneen Shalabi
Haneen Shalabi, D.O. (center) is the 5th Annual Giant Food NextGen Award winner from The
National Cancer Institute, focusing her research on Acute Lympoblastic Leukemia & B-cell Lymphomas.
2016 Next Gen Award Winner: Dr. Jeffrey Rubens
Dr. Rubens is a pediatric hematology-oncology clinical and research fellow at Johns Hopkins Hospital. His focus is on LIN-28 in atypical rhabdoid tumors of the brain to help understand the malignant transformation of normal brain tissue and to help find curative therapeutics for this deadly tumor.
2015 Next Gen Award Winner: Dr. Patrick Hanley
Dr. Hanley is a research assistant professor in the division of blood and marrow transplantation and director of the William and Shirley Howard Cell Therapy Laboratory at Children’s National Health System. In addition to clinical-grade manufacturing, he is interested in translating novel cell therapies into the clinic. Over the past ten years, Dr. Hanley has helped to develop T cell therapies that attack viruses and cancer after stem cell transplantation and has recently focused on developing similar therapies for recipients of cord blood transplantation. Dr. Hanley is the Co-chair of the International Society For Cellular Therapy (ISCT) Early Stage Professionals Committee and is a member of ISCT’s Immunotherapy committee.
2014 Next Gen Award Winner: Nirali Shah, M.D.
Dr. Shah focuses on the implementation and conduct of clinical trials with a specific focus on immune-based therapies, targeting relapsed refractory leukemia, especially in the treatment of patients with post- transplant relapse. Her clinical trials include several Phase I trials for the treatment of relapsed/refractory pediatric acute lymphoblastic leukemia (ALL). Based on these trials, she has developed a niche for the translation of immunotherapy-based strategies for the treatment of relapsed/refractory leukemia. She currently serves as Principal Investigator in the Pediatric Oncology Branch of the National Cancer Institute.
Areas of expertise include pediatric acute leukemia, hematopoietic stem cell transplantation, phase I/II clinical trials, relapsed leukemia, bioethics and cellular therapy.
2013 Next Gen Award Winner: Leslie Doros, M.D.
On October 8, 2013, Giant Food of Landover, Md. in conjunction with the Children’s Cancer Foundation, Inc., presented the first-ever Giant Food NextGen Award for Children’s Cancer Research to Dr. Leslie Doros, of Children’s National Health System· This $100,000 grant was created specifically for young investigators who are committed to pursuing a long-term career in Pediatric Oncology research and was made possible with funds raised through Giant’s annual Triple Winner program.
Leslie Doros, MD, is a pediatric oncologist at Children’s National Health System in Washington, DC. She completed her medical degree at the Medical University of South Carolina, her pediatric residency training at Le Bonheur Children’s Hospital in Memphis, TN, and her pediatric hematology/oncology fellowship at Children’s National.